I
Iconix Biosciences
A toxicogenomics database of microarray and pharmacology data with the expertise to interpret it
About Iconix Biosciences
Iconix Biosciences is a pioneering company in the healthcare sector, specializing in the development of virtual reality (VR) solutions aimed at improving patient care and medical training. The company serves a diverse range of clients including hospitals, medical schools, and mental health institutions. Operating within the healthcare technology market, Iconix Biosciences leverages VR to create immersive experiences that help patients manage anxiety and pain during hospital stays, and enable medical students to virtually attend and learn from a wide array of medical procedures. The business model revolves around the development and licensing of VR applications, such as the VisitU app, which allows patients to connect with loved ones, and educational platforms that offer a library of prerecorded and live-streamed VR operations for medical students. Revenue is generated through subscription fees, licensing agreements, and partnerships with healthcare institutions.
Source: Dealroom company dataNews
Open roles
Iconix Biosciences in the Mountain View ecosystem
The Iconix Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Iconix Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Iconix Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
